Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
2.
Semin Arthritis Rheum ; 57: 152101, 2022 12.
Artigo em Inglês | MEDLINE | ID: mdl-36183478

RESUMO

OBJECTIVES: To develop evidence-based expert recommendations for non-pharmacological treatments for pain, fatigue, sleep problems, and depression in fibromyalgia. METHODS: An international, multidisciplinary Delphi exercise was conducted. Authors of EULAR and the Canadian Fibromyalgia Guidelines Group, members of the American Pain Society and clinicians with expertise in fibromyalgia were invited. Participants were asked to select non-pharmacological interventions that could be offered for specific fibromyalgia symptoms and to classify them as either core or adjunctive treatments. An evidence summary was provided to aid the decision making. Items receiving >70% votes were accepted, those receiving <30% votes were rejected and those obtaining 30-70% votes were recirculated for up to two additional rounds. RESULTS: Seventeen experts participated (Europe (n = 10), North America (n = 6), and Israel (n = 1)) in the Delphi exercise and completed all three rounds. Aerobic exercise, education, sleep hygiene and cognitive behavioural therapy were recommended as core treatments for all symptoms. Mind-body exercises were recommended as core interventions for pain, fatigue and sleep problems. Mindfulness was voted core treatment for depression, and adjunctive treatment for other symptoms. Other interventions, namely music, relaxation, hot bath, and local heat were voted as adjunctive treatments, varying between symptoms. CONCLUSIONS: This study provided evidence-based expert consensus recommendations on non-pharmacological treatments for fibromyalgia that may be used to individualise treatments in clinical practice targeting the diverse symptoms associated with fibromyalgia.


Assuntos
Fibromialgia , Transtornos do Sono-Vigília , Humanos , Fibromialgia/terapia , Consenso , Técnica Delphi , Canadá , Fadiga/etiologia , Fadiga/terapia , Dor
5.
Curr Pain Headache Rep ; 7(6): 433-42, 2003 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-14604502

RESUMO

Myofascial pain syndrome (MPS) and fibromyalgia (FM) are complex conditions and pose significant challenges to clinicians and patients. This chapter explores available treatments for MPS and FM in the context of pathophysiology, clinical evidence, and experimental support. This information may prove to be helpful in designing individualized treatment for patients with these complex syndromes. New treatments should be critically and carefully evaluated as they appear.


Assuntos
Fibromialgia/terapia , Síndromes da Dor Miofascial/terapia , Animais , Fibromialgia/tratamento farmacológico , Fibromialgia/psicologia , Humanos , Síndromes da Dor Miofascial/tratamento farmacológico , Síndromes da Dor Miofascial/psicologia
6.
Anesth Analg ; 99(5): 1478-1485, 2004 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-15502052

RESUMO

We have demonstrated that subjects with complex regional pain syndrome (CRPS) have asymmetric venous pool plasma concentrations of norepinephrine (NE) when affected and unaffected limbs are compared, with most demonstrating decreased NE levels in the affected limb. This pilot study explored whether systemic venous plasma catecholamine levels in CRPS subjects with sympathetically maintained pain (SMP) differ from those found in healthy volunteers. We also explored whether catecholamine levels were correlated with scores on psychometric measures of depression, anxiety, and personality. Venous blood samples from 33 CRPS/SMP patients (from unaffected limbs) and 30 healthy control subjects were assayed for plasma NE and epinephrine (E) concentrations. Plasma NE levels were significantly higher in the CRPS group (P < 0.001). Statistical comparisons of E levels across groups did not achieve significance (P < 0.06), although 52% of CRPS/SMP patients had E levels exceeding the 95% confidence interval based on control data. Significant positive correlations were found between E levels and scores on the Beck Depression Inventory and Scales 1, 3, and 6 on the Minnesota Multiphasic Personality Inventory-2 (all P < 0.05). This preliminary work suggests that increased NE and E levels in CRPS/SMP patients may result from the pain of CRPS, consequent affective distress, or both. Alternatively, our findings could reflect premorbid adrenergic hyperactivity caused by affective, endocrine, or other pathology, which might predispose these individuals to develop the syndrome. Definitive studies are needed to examine these hypotheses in detail.


Assuntos
Catecolaminas/sangue , Síndromes da Dor Regional Complexa/sangue , Síndromes da Dor Regional Complexa/psicologia , Adulto , Envelhecimento/metabolismo , Ansiedade/diagnóstico , Ansiedade/psicologia , Cromatografia Líquida de Alta Pressão , Síndromes da Dor Regional Complexa/terapia , Depressão/diagnóstico , Depressão/psicologia , Eletroquímica , Epinefrina/sangue , Feminino , Humanos , Masculino , Testes Neuropsicológicos , Norepinefrina/sangue , Medição da Dor , Projetos Piloto , Escalas de Graduação Psiquiátrica , Psicometria
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA